National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries

National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries

Abstract Given rising diabetes prevalence globally, access to diabetes treatments is gaining urgency. Yet, it remains unknown which glucose-lowering medication types people with diabetes across low- and middle-income countries (LMICs) use. In this cross-sectional analysis, we pooled nationally repre...

Full description

Saved in:
Bibliographic Details
Main Authors: Felix Teufel, Pia Roddewig, Maja E. Marcus, Michaela Theilmann, Glennis Andall-Brereton, Krishna Aryal, Sina Azadnajafabad, Pascal Bovet, Maria Dorobantu, Farshad Farzadfar, Corine Houehanou, Abla Sibai, Andrew C. Stokes, Demetre Labadarios, Mongal Gurung, Jutta Jorgensen, Khem Karki, Nuno Lunet, Sahar Saeedi Moghaddam, Kibachio J. Mwangi, Lela Sturua, Till Bärnighausen, David Flood, Pascal Geldsetzer, Albertino Damasceno, Justine Davies, Sebastian Vollmer, Mohammed K. Ali, Jennifer Manne-Goehler, Caroline Bulstra
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-59123-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41467-025-59123-4

Similar Items